64x Bio (Summer 2018) - Startups.RIP

Back to all companies

64x Bio (Summer 2018) - Startups.RIP

Back to all companies

64x Bio

Summer 2018Active

The future of medicine is taking shape, but scaling it remains a challenge. Some of the biggest breakthroughs in next generation therapies are being held back by manufacturing constraints. The science is moving fast, but the infrastructure is still catching up. Our VectorSelect platform is designed to unlock the scale these therapies need to survive. We combine massively parallelized screens with computational insights to engineer high yield cell lines and production technologies — accelerating the manufacturing of advanced therapies from the inside out.

Founded

Unknown

Category

Gene Therapy

YC Company Page www.64xbio.com

No report yet — want us to research it?

This company has not been analyzed yet. Request a research report and we will email you when it is ready to view.

We will notify you as soon as the analysis is complete.